Skip to main content
Erschienen in: BMC Ophthalmology 1/2024

Open Access 01.12.2024 | Research

Novel surgical approaches for treating myopic traction maculopathy: a meta-analysis

verfasst von: Miguel A. Quiroz-Reyes, Erick A. Quiroz-Gonzalez, Miguel A. Quiroz-Gonzalez, Virgilio Lima-Gomez

Erschienen in: BMC Ophthalmology | Ausgabe 1/2024

Abstract

Background

Myopic traction maculopathy (MTM) is a complication of pathological myopia and encompasses various pathological conditions caused by tractional changes in the eye. These changes include retinoschisis, foveal retinal detachment, and lamellar or full-thickness macular holes (FTMHs). This meta-analysis evaluated the safety and efficacy of novel surgical for treating MTM.

Methods

To compare the outcomes of different surgical approaches for MTM, multiple databases, including Web of Science, PubMed, Scopus, ClinicalTrials.gov, the Cochrane Central Register of Controlled Trials, Ovid MEDLINE, Embase, and the Meta-Register of Controlled Trials, were comprehensively searched. The meta-analysis was performed using RevMan 5.1.

Results

Nine comparative studies involving 350 eyes were included in this meta-analysis. There were significant differences between fovea-sparing internal limiting membrane peeling (FSIP) and standard internal limiting membrane peeling (ILMP). Preoperative best-corrected visual acuity BCVA (standard mean difference (SMD): -0.10, 95% CI: -0.32 to 0.12) and central foveal thickness CFT (SMD: 0.05, 95% CI: -0.22 to 0.33) were not significantly different (p = 0.39 and p = 0.71, respectively). However, the postoperative BCVA improved significantly (SMD = − 0.47, 95% CI: − 0.80, − 0.14, p = 0.006) in the FSIP group compared to the standard ILMP group. Postoperative CFT did not differ significantly between the two groups (p = 0.62). The FSIP group had a greater anatomical success rate than the other groups, although the difference was not statistically significant (p = 0.26). The incidence of postoperative macular hole formation was significantly lower (OR = 0.19, 95% CI = 0.07–0.54; p = 0.05) in the FSIP group than in the standard ILMP group. The unique characteristics of highly myopic eyes, such as increased axial length and structural changes, may have contributed to the greater incidence of FTMH in the ILMP group.

Conclusion

Based on the findings of this meta-analysis, FSIP is the initial surgical approach for early-stage MTM and has shown promising outcomes. However, to establish the safest and most efficient surgical technique for treating different MTM stages, further comparative studies, specifically those focusing on ILMP and FSIP, are necessary.

Trial registration

Retrospectively registered.
Begleitmaterial
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12886-024-03374-0.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ABC
Autologous blood cells
AL
Axial length
AMG
Amnios membrane grafting
ART
Autologous retinal transplantation
BCVA
Best-corrected visual acuity
CENTRAL
Cochrane Central Register of Controlled Trials
CFT
Central foveal thickness
CI
Confidence interval
CR
Complete reattachment
ERMs
Epiretinal membranes
FRD
Foveal retinal detachment
FSIP
Fovea-saving internal limiting membrane
FTMH
Full-thickness macular hole
ILMP
Internal limiting membrane peeling
logMAR
Logarithm of the minimum angle of resolution
MB
Macular buckling
MH
Macular hole
MHRD
Macular hole retinal detachment
ML-IILM
Multilayered inverted internal limiting membrane
MINORS
Methodological Index for Nonrandomized Studies
MTM
Myopic traction maculopathy
NOS
Newcastle‒Ottawa Scale
OCT
Optical coherence tomography
ODDs
Odds ratios
PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-analysis
PPV
Pars plana vitrectomy
PM
Pathological myopia
PS
Posterior staphyloma
RCTs
Randomized controlled trials
RD
Retinal detachment
RS
Retinoschisis
SMD
Standardized mean deviation
WMD
Weighted mean difference

Background

Myopic traction maculopathy (MTM) is characterized by significant retinoschisis-like thickening of the outer retina accompanied by posterior staphyloma (PS) in highly myopic eyes [1]. MTM is considered a major complication of pathologic myopia (PM) and is projected to become a leading cause of visual impairment worldwide in the coming decades [2, 3]. The prevalence of visual impairment and blindness associated with PM ranges from 12 to 27% in Asian populations and 7% in Western populations [36]. MTM has been identified and categorized via the extensive application of OCT and vitrectomy techniques [7]. Additionally, studies have reported the occurrence of epiretinal membranes (ERMs), macular retinoschisis (RS), stretched retinal vessels, different degrees of posterior staphyloma (PS), outer lamellar macular holes (MHs), full-thickness MHs (FTMHs), abnormally rigid inner limiting membrane (ILM), foveal retinal detachment (FRD), and MH retinal detachment (MHRD) [3, 810]. MTM progression is driven by increasing traction exerted on these structures [11].
The ab externo surgical approach for MTM was introduced long before its definition in 1930. In terms of treatment, surgery is recommended for patients with reduced visual acuity, detached fovea, FTMH, or champagne-flute-shaped retinoschisis and MHRD [12, 13]. Surgical treatment options include pars plana vitrectomy (PPV) with or without ILM stripping and macular buckling (MB) [14, 15]. In 1957, Schepens et al. proposed the MB technique, which has since been considered the best surgical approach for the treatment of myopic MHRD [16]. In 2012, Shimada et al. presented an innovative approach to myopic FRD surgery known as fovea-sparing internal limiting membrane peeling (FSIP). In contrast to the standard ILM peeling (ILMP) technique, the FSIP technique retains a portion of the ILM attached to the fovea, demonstrating greater efficacy in preventing MH development [17, 18]. Recently, several novel surgical methods, including autologous neurosensory retinal-free patch transplantation [19], lens capsular flap transplantation [20], ILM repositioning with autologous blood clotting (ABC) [21] and inverted ILM insertion [22], have been proposed for MTM. According to Michalewska et al., the postoperative closure rate using the inverted ILM flap technique was better (98%) for large idiopathic MHs than for small idiopathic MHs [23]. Following the same procedure as that used for myopic MH treatment, Kuriyama et al. [22] reported a closure rate of 80%. Recently, Chen et al. [24] reported a closure rate of 100% using inverted ILM insertion for MHRD in highly myopic patients.
Numerous surgical techniques are available for the treatment of MTM, but there is no standard treatment approach. Recent advancements in various surgical techniques have introduced new viable options for MTM treatment [25]. However, it is necessary to thoroughly examine these studies to validate their effectiveness and ensure their methodological rigor in assessing the efficacy of surgical treatments for MTM. Careful evaluation of their methodology, study design, and outcome assessments is required to derive compelling and coherent conclusions regarding their impact on patients. Therefore, we conducted a comprehensive review and meta-analysis of clinical studies involving MTM patients who underwent surgical treatment. This study aimed to compare the outcomes of different surgical treatments for MTM. Numerous studies have reported that the application of the FSIP technique for treating MTM leads to improved visual and anatomical outcomes [26, 27]. This meta-analysis aimed to increase the sample size, obtain more reliable findings to validate previous studies, and provide updates on the preferred surgical approach based on recently published studies.

Methods

Search strategy

The search was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Database searches of the literature were conducted by using PubMed, ClinicalTrials.gov (www.​clinicaltrials.​gov), Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL), which contains the Cochrane Eyes and Vision Group Trials Register (The Cochrane Library 2013, Issue 2); Ovid MEDLINE; Ovid MEDLINE In‐Process and Other Non-Indexed Citations, Ovid MEDLINE Daily; Ovid OLDMEDLINE (January 1990 to October 2020); Embase (January 2000 to October 2022); and the metaRegister of Controlled Trials (mRCT) (www.​controlled-trials.​com). In all of these databases, specific keywords were used to narrow the results to the desired literature (Supplementary file). The reference lists of the studies included in the review were also searched for information on other studies on the use of ILMPs for the surgical treatment of MTM. The databases were ultimately searched on October 12, 2022, and an additional search was performed using Google Scholar to identify the reference lists of the originally identified articles. No language restrictions were placed on the electronic searches for the trials.

Screening of the retrieved studies

Two authors screened studies using the Covidence.org tool. The title and abstract of each publication were reviewed by two reviewers (MAQR and EAQG), who selected the studies relevant to our desired objectives. Following the initial screening, disagreements were discussed and resolved by the two reviewers. If an agreement could not be reached, a third reviewer (VLG) was consulted to arbitrate the study.

Study selection criteria

Studies involving individuals with highly myopic eyes, defined by an axial length (AL) longer than 26.5 mm or a refractive error of more than -6.0 diopters, who exhibited myopic foveoschisis leading to gradual vision loss were included in the study. The detailed inclusion and exclusion criteria were as follows:
Criteria Type
Inclusion Criteria
Exclusion Criteria
Study Design
Comparative Prospective and retrospective studies, Conference Abstracts with all the required data
Studies such as noncomparative studies, single-arm studies, animal studies, conference abstracts with limited data or that present data from previous studies, review articles, doctoral dissertations, articles that present data from the same study, and case reports
Surgical Approach
Vitrectomy using various techniques, including the classical ILMP technique, FSIP techniques, inverted ILM insertion, ILM flap with ABC technique, lens capsule transplantation, multilayered inverted ILM (ML-IILM) techniques, autologous neurosensory retina grafting techniques, and human amnion membrane grafting (AMG) technique
Use of macular buckling techniques
Publication Language
English
Other than English
Follow-up durations
More than or equal to 6 months
Less than 6 months

Types of intervention

The following intervention comparisons were considered: standard ILMP technique versus FSIP, inverted ILM insertion versus ILM flap with the ABC technique, lens capsule transplantation versus ML-IILM techniques, and autologous neurosensory retinal grafting (ARG) techniques versus the human AMG technique.

Outcome measures

The primary outcomes of the study were as follows: (a) visual outcome measures, that is, postoperative changes in best-corrected visual acuity (BCVA); (b) anatomic outcome measures, that is, the proportion of patients with foveal (retinal) reattachment and the mean change in central foveal thickness (CFT); and (c) the postoperative incidence of MHs and complications.

Data extraction

Each article was evaluated after a database search to determine whether it was unquestionably relevant, perhaps relevant, or certainly irrelevant. All the articles were checked for inclusion or exclusion after duplicates were removed. The study design, reports, and final results of all the included studies were thoroughly reviewed. Two surgeons (MAQR and EAQG) checked all the publications retrieved during the search, selected studies that met the inclusion criteria, and gathered data from those studies. The name of the first author, year of publication, number of participants in each group, refractive error, axial length, preoperative and postoperative BCVA, percentage of patients with CR and MH, mean change in CFT, and length of follow-up were extracted from the list of items.

Methodological assessment and statistical analysis

We used a modified checklist derived from the Newcastle–Ottawa Scale (NOS) to assess the quality of the studies included in the meta-analysis. The assessment encompassed three categories: selection, comparability, and exposure/outcome. Each category comprised specific criteria, with studies scoring points based on adherence to these criteria [20]. A nine-point scale was used for evaluation, with studies categorized as high, medium, or poor quality based on their scores. Studies meeting a threshold of > 4 points on the NOS were considered for the final analysis, and those scoring < 3 points were excluded. Additionally, the quality of the randomized controlled trials (RCTs) was evaluated using the 5-point Jadad scale.

Statistical analysis

To assess heterogeneity among studies, Cochrane's Q statistic and the I^2 statistic were used. The Cochrane Review Manager (RevMan) software was used to analyze continuous variables via weighted mean difference (WMD) calculations and computed odds ratios (ORs) for dichotomous variables. Confidence intervals (CIs) were calculated using an established methodology [28]. Publication bias was examined using funnel plots and tested via Begg’s rank correlation and Egger’s linear regression tests, with significance set at p < 0.05 [29, 30].

Results

After the database searches, 273 articles were retrieved using various keywords. Initially, reviews, case reports, correspondences, abstracts, and irrelevant documents were excluded. Subsequently, 34 additional studies were excluded after screening the titles and abstracts. Among the remaining studies, five were excluded because of insufficient data and irrelevant interventions. Upon assessment of the full text, 10 English studies were deemed eligible for meta-analysis (Fig. 1). Of these, nine studies compared standard ILMP to FSIP, while one study compared inverted ILM insertion versus the ILM flap with the ABC technique; these studies were not included in the meta-analysis. All nine selected studies were comparative nonrandomized and retrospective studies. No other novel comparative interventions were identified in this study.

Characteristics of the included studies

A total of 350 eyes were included in the nine studies. Approximately 141 eyes underwent FSIP, and 209 eyes underwent standard ILMP. Eight studies were retrospective, whereas one study was prospective. The detailed characteristics of the studies are presented in Table 1. The results of the quality assessment are presented in Table 2. All the included patients were diagnosed with MTM and had an AL > 26.5 mm. Moreover, there were no significant differences in the preoperative BCVA or CFT between the two groups, as shown in Fig. 2(a) and (b). (BCVA: standardized mean deviation (SMD): -0.10, 95% CI = -0.32 to 0.12, p = 0.39; CFT: SMD: 0.05, 95% CI = -0.22 to 0.33, p = 0.71).
Table 1
Characteristics of the studies included in the meta-analysis
Study design
Study conducted by
No of eyes
Average age in years
AL (mm)
Treatment
ILM staining
Tamponade
Preoperative foveal retinal detachment (%)
Preoperative ERM
Preoperative- CFT (μm)
Postoperative- CFT (μm)
Preoperative BCVA (LogMAR)
Postoperative BCVA (LogMAR)
Preoperative MH
Postoperative MH
Follow-up (months)
Retrospective
Xin et al. [31]
18
56.78 ± 5.75
27.59 ± 0.57
FSIP
Indocyanine green
Air
5 (27.78)
-
889.72 ± 118.27
134.94 ± 21.49
1.69 ± 0.19
1.13 ± 0.21
0
0
6 months
 
16
57.75 ± 6.37
27.55 ± 0.70
Standard ILMP
Indocyanine green
Air
3 (18.75)
-
892.44 ± 126.15
149.44 ± 19.60
1.66 ± 0.19
1.45 ± 0.11
0
2
6 months
Retrospective
Wang et al. [13]
15
65.8 ± 7.1
29.1 ± 1.1
FISP
Indocyanine green
Gas
15
-
-
-
0.65 ± 0.5
0.34 ± 0.4
0
0
11.3 ± 5.3
 
30
63.2 ± 12.0
29.1 ± 1.8
Standard ILMP
Indocyanine green
Gas
30
-
-
-
0.74 ± 0.5
0.58 ± 0.6
0
5
47.5 ± 18.5
Prospective
Elwan et al. [32]
13
54.54 ± 6.4
29.2 ± 9.05
FSIP
Brilliant blue G (BBG)
Gas
-
-
687.08 ± 150.20
168.38 ± 44.41
1.68 ± 0.3
0.7 ± 0.26
0
0
12 months
 
15
54.67 ± 5.7
29.15 ± 11.87
Standard ILMP
Brilliant blue G (BBG)
Gas
-
-
671.53 ± 157.8
156.47 ± 45.8
1.56 ± 0.3
0.83 ± 0.23
0
0
12 months
Retrospective
Iwasaki et al. [33]
11
71.8 ± 6.7
29.7 ± 1.8
FSIP
Brilliant blue G (BBG)
Gas
6 (54.5)
8 (72.7)
557.60 ± 270.00
128.80 ± 46.50
0.61 ± 0.43
0.34 ± 0.42
0
0
17.1 months
 
11
70.4 ± 9.7
28.8 ± 1.6
Standard ILMP
Brilliant blue G (BBG)
Gas
5 (45.5)
6 (54.5)
547.30 ± 213.70
130.30 ± 38.00
0.65 ± 0.31
0.52 ± 0.43
0
3
40.3 months
Retrospective
Wang et al. [34]
13
50.0 ± 9.6
29.3
FSIP
Brilliant blue G (BBG)
C3F8 gas
6 (46)
0
507.68 ± 53.80
308.30 ± 65.45
1.1 (0.8–1.7)
0.9 (0.6–1.2)
0
1
6 months
 
20
50.1 ± 9.3
28.95
Standard ILMP
Brilliant blue G (BBG)
C3F8 gas
8 (40)
0
522.87 ± 50.31
312.94 ± 45.50
1.1 (0.8–1.7)
0.9 (0.7–1.2)
0
2
6 months
Retrospective
Shiraki et al. [35]
26
65.2 ± 10.8
30.1 ± 1.9
FSIP
Brilliant blue G (BBG)
Sulfur hexafluoride gas
8
-
-
-
0.60 ± 0.35
0.32 ± 0.43
12
0
21.5 ± 9.0
 
76
65.5 ± 9.3
29.3 ± 1.4
Standard ILMP
Brilliant blue G (BBG)
Sulfur hexafluoride gas
29
-
-
-
0.61 ± 0.39
0.37 ± 0.38
0
6
25.8 ± 10.3
Retrospective
Tian et al. [27]
18
52.80 ± 10.80
-
FSIP
Brilliant blue G (BBG)
Fluid air exchange
10 (55.6)
-
615.17 ± 169.7
143.36 ± 52.40
1.46 ± 0.80
0.56 ± 0.30
0
3
20.9 ± 9.6
 
18
58.00 ± 13.20
-
Standard ILMP
Brilliant blue G (BBG)
Fluid air exchange
9 (50)
-
631.60 ± 146.30
141.60 ± 93.40
1.11 ± 0.80
0.67 ± 0.50
1
1
19.6 ± 4.1
Retrospective
Ho et al. [26]
12
58.20 ± 10.50
-
FSIP
Indocyanine green
-
4
-
815.00 ± 302.00
122.00 ± 67.00
1.70 ± 0.40
0.89 ± 0.56
-
0
55.6 ± 16.2
 
7
54.40 ± 6.50
-
Standard ILMP
Indocyanine green
-
7
-
783.00 ± 215.0
137.00 ± 52.0
1.67 ± 0.23
1.39 ± 0.33
-
2
52.4 ± 14.6
Retrospective
Zhu et al. [36]
15
57.55 ± 9.45
-
FSIP
-
-
-
-
578.33 ± 200.18
134.27 ± 25.29
1.11 ± 0.35
0.64 ± 0.21
-
0
18.65 ± 5.15 months
 
16
-
Standard ILMP
-
-
-
-
596.51 ± 196.69
126.25 ± 36.61
1.03 ± 0.33
0.67 ± 0.24
-
1
The numbers in the "postoperative macular hole (MH)" column represent the number of eyes with postoperative macular hole (MH) formation. Specifically, 0 corresponds to patients with no MH, 1 indicates one patient, and 2 indicates two patients with MH
FSIP Fovea-sparing internal limiting membrane peeling, standard ILMP standard internal limiting membrane peeling, AL Axial length, ERM Epiretinal membrane, CFT Central foveal thickness, BCVA Best corrected visual acuity
Table 2
MINORS for assessing the quality of included studies
Methodological item for nonrandomized studies
Elwan et al. [32]
Wang et al. [13]
Shiraki et al. [35]
Wang et al. [34]
Iwaski et al. [33]
Xin et al. [31]
Tian et al. [27]
Ho et al. [26]
Zhu et al. [36]
1. A clearly stated aim
2
2
2
2
2
2
2
2
2
2. Inclusion of consecutive patients
2
2
2
2
2
2
2
2
2
3. Prospective collection of data
2
0
0
0
0
0
0
0
0
4. Endpoints appropriate to the aim of the study
2
2
2
2
2
2
2
2
1
5. Unbiased assessment of the study endpoint
1
1
1
1
1
1
1
1
1
6. Follow-up period appropriate to the aim of the study
2
2
2
2
2
2
2
2
2
7. Loss to follow up less than 5%
2
2
2
2
2
2
2
2
2
8. Prospective calculation of the study size
0
0
0
0
0
0
0
0
0
9. An adequate control group
2
2
2
2
2
2
2
2
1
10. Contemporary groups
2
1
2
2
2
2
2
2
1
11. Baseline equivalence of groups
2
2
2
2
2
2
2
2
2
12. Adequate statistical analyses
2
2
1
2
2
2
2
2
1
13. MINORS score
20
18
18
19
19
19
19
19
15

Visual outcome efficacy analysis

After analyzing all the included studies, we found that BCVA improved postoperatively in both groups, excluding patients who developed MHs. However, the overall improvement across both groups was not statistically significant. The postoperative BCVA showed a greater change in the FSIP group than in the standard ILMP group. As shown in Fig. 3 (SMD = − 0.47, 95% CI: − 0.80, − 0.14, p = 0.006), the postoperative increase in BCVA was highly significant.

Measures of anatomic outcomes

In six studies [27, 3134, 36] involving 201 eyes, there was a significant decrease in postoperative CFT. However, in this meta-analysis, we did not find a statistically significant difference between the two groups, as shown in Fig. 4(a) (SMD = 0.07, 95% CI = -0.21 to 0.35; p = 0.62). Four studies [13, 26, 31, 34] reported the rate of anatomic success in 125 eyes and reported that the standard ILMP method was associated with a significantly greater probability of anatomic success (Fig. 4(b)) (OR = 0.53, 95% CI = 0.18 to 1.61; p = 0.26). These findings suggest that postoperative MH formation is greater after standard ILMP than after FSIP.

Postoperative complications

Eight studies reported postoperative complications, such as MH and RD, in patients who underwent FSIP compared to those who underwent standard ILMP. The most serious postoperative complication was MH formation; no intraoperative complications were reported. After excluding two studies [32, 36], the remaining five studies [26, 27, 31, 3335] showed that FSIP was significantly superior to standard ILMP for preventing MH formation (OR = 0.19, 95% CI = 0.07–0.54; p = 0.05), as shown in Fig. 5. One study reported no postoperative complications [13].

Sensitivity analysis

We conducted sensitivity analyses to examine the impact of FSIP on vision, specifically excluding individuals without postoperative MHs from the analysis. The results did not reveal any significant change in vision (p = 0.56), and the odds ratio was 1.67, with a 95% confidence interval of 0.30–9.34. The I2 statistic, which measures the percentage of variability across studies due to heterogeneity rather than chance, was 0%, indicating a low variability (Fig. 6). These findings suggest that even in patients without postoperative MH, the positive impact of FSIP on vision was not significantly different.

Publication bias

The funnel plot in Fig. 7 shows that the proportion of MH formation in MTM was symmetrical. No statistically significant evidence of publication bias was found according to Begg's test (p = 0.38) or Egger's test (p = 0.47).

Research gap: absence of comparative studies to date

The only study comparing inverted ILM insertion and the ILM flap with the ABC technique for MTM was not included in this meta-analysis. Our meta-analysis focused on all the novel surgical techniques used for MTM, but no additional comparative studies were found to date. According to Hu et al. [25], the MH closure rate was 96% when the ILM flap was used with the ABC technique and 92% when the inverted ILM insertion technique was used (Table 3). This study supports the use of an ILM flap with the ABC technique. However, these findings should be validated in future studies.
Table 3
Inverted ILM flap insertion versus the ILM flap insertion with the autologous blood technique
Study design
Study conducted by
No of eyes
Average age in years
Macular Hole (MH) mean diameter
Treatment
Superficial foveal avascular zone (FAZ)
Superficial parafoveal vessel density
Preoperative BCVA (LogMAR)
Postoperative BCVA (LogMAR)
Macular Hole (MH) closure rate
Follow Up months
Retrospective
Hu et al. [25]
25
62.2 ± 11.0
700 μm
ILM flap with Autologous blood technique
0.29 ± 0.08 mm2
51.41 ± 2.79%
1.31 ± 0.61
0.68 ± 0.40
96%
3 months
27
64.4 ± 9.3
700 μm
Inverted ILM insertion
0.73 ± 0.15 mm2
43.77 ± 2.71%
1.34 ± 0.39
1.29 ± 0.62
92.5%
3 months

Discussion

We conducted a meta-analysis of nine studies to evaluate the safety and efficacy of FSIP versus standard ILMP for MTM. A total of 350 eyes were included; 141 eyes were subjected to FSIP treatment, while 209 eyes were treated with standard ILMP. Both groups exhibited similar anatomical outcomes; however, these results support the use of the FSIP technique, which yields better postoperative visual outcomes based on the mean change in logMAR BCVA from baseline. There was a significant difference in the incidence of postoperative MHs between the two groups. Specifically, the postoperative MH rate was lower in the FSIP group (4.25%) than that in the standard ILMP group (8.6%).
According to a meta-analysis by Wu et al. [37], the FSIP group achieved a better postoperative BCVA; however, a comparison of postoperative BCVA was insufficient because differences may have existed at baseline, affecting the postoperative findings. Therefore, we determined the mean change in logMAR BCVA from baseline and observed that the FSIP group had a greater mean improvement than the standard ILMP group. The greater percentage of postoperative MHs in the standard ILMP group might be the reason for the improvement in BCVA in the FSIP group because the visual prognosis is poor in patients with high myopia and MHs [38]. This statement is supported by (Ho et al., 2014) [26], who observed a greater rate of inner/outer segment (IS/OS) line restoration in the FSIP group (9/12) than in the standard ILMP group (1/7), which might have contributed to the better final BCVA. According to Rubinstein et al. [39], FTMH occurs after surgery because of ILM-induced trauma. Moreover, they proposed that bleeding occurs in a small area during peeling, leading to postoperative FTMH. In addition, Hussain and Mitra [40] reported that ILM detachment may cause mechanical damage to the inner retina, which may lead to apoptosis of glial cells, resulting in degeneration of neurons and contributing to the formation of postoperative FTMHs. Based on our findings and those of previous research, the unique characteristics of highly myopic eyes, such as increased axial length and structural changes, may have contributed to the greater incidence of FTMH in the ILMP group. These factors may influence the healing process differently in symptomatic eyes compared to healthy eyes.
Importantly, different surgeons have different remnant foveolar ILM diameters in the FSIP. In a study by Wang et al. (2012) [13], the foveal ILM diameter was preserved along the vertical extent of the optic disc. Subsequently, (Elwan et al., 2019) [32] and (Iwasaki et al., 2020) [33] followed the same technique as Shimada et al.; however, the exact diameter was not specified by Elwan et al., while Iwasaki’s group left a 0.5 to 1.0 disc diameter. The size of the preserved ILM was one papillary diameter (PD) in the study by Wang et al. (2019) [34], while in the study by Xin et al. (2022) [31], an ILM of approximately 1 to 1.5 papillary diameter centered on the fovea centralis was retained, whereas in the standard ILMP group, it was completely removed from 16 eyes. The VA and foveolar structure did not deteriorate over the course of follow-up, which was expected given the assumption that any persisting ILM would function as a preretinal membrane. However, (Ho et al., 2014) [26] and (Tian et al., 2018) [27] chose to reserve ILMs with diameters of 300–500 μm and 500 μm, respectively, because they found that these sizes were suitable for complete foveolar covering and adequate traction release. To the best of our knowledge, the preservation of a smaller section produces better results because the probability of recurrence is lower; however, additional expert surgeries are needed. However, the aforementioned research findings were satisfactory, and it is unlikely that size has an impact on the outcome. Currently, there is no consensus on the extent to which the foveolar ILM should be preserved; thus, further comparative studies and long-term follow-up are needed.
The results of this meta-analysis should be evaluated with caution due to several limitations. One major limitation is that we did not find any comparative studies on novel surgical approaches. After an in-depth search, we found only one comparative study that was not included in the meta-analysis because no other comparative studies were conducted for the same intervention. Future studies should be conducted on these interventions to assess their safety and efficacy. Among the nine included studies, eight were retrospective, and the only prospective study was not randomized. Prospective RCTs with larger sample sizes are required to obtain more conclusive results. Nonetheless, nonrandomized clinical trials contain many uncontrollable factors and lack sufficient data to draw precise conclusions. Moreover, the number of eyes, tamponades, dyes used to stain the ILM, and follow-up times were different in all studies; however, these aspects were not highlighted in this meta-analysis. The follow-up periods of the studies were different and covered an extensive range, from 6 months (Elwan et al., 2019) [32] to more than four years (Ho et al., 2014) [26], which had an impact on the results. In some investigations, the exact time at which the postoperative BCVA was measured was not adequately described; this may have coincided with the end of the follow-up. This meta-analysis included only 350 eyes and aggregated the results from previously published studies; however, these results did not fulfill the standards for an effective meta-analysis. Therefore, additional clinical RCTs with larger sample sizes are warranted. Different FSIP techniques resulted in different sizes of preserved ILMs after surgery, which may have influenced our results. Although these limitations affect the reliability of the conclusions, the results are valuable for demonstrating the superiority of the FSIP technique.

Conclusion

In conclusion, the present meta-analysis of published studies showed that FSIP is an efficient and safe procedure for the treatment of the initial stages of MTM, with a higher rate of macular reattachment and a lower rate of MH formation than the standard ILMP method. Therefore, FSIP may be the preferred treatment for high myopia conditions such as MTM; however, for patients in the late and advanced stages, we need to implement other novel surgical options, which cannot yet be determined owing to a lack of available studies.

Acknowledgements

The authors thank the researchers of the original studies that were included in this meta-analysis. We would like to express our deep appreciation to the technical and statistical staff of the Retina Department of Oftalmologia Integral ABC (Nonprofit Medical and Surgical Organization), Mexico City, Mexico.

Declarations

None required.
None required.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary Information

Literatur
1.
Zurück zum Zitat Johnson MW. Myopic traction maculopathy: pathogenic mechanisms and surgical treatment. Retina (Philadelphia, Pa). 2012;32:S205–10.CrossRefPubMed Johnson MW. Myopic traction maculopathy: pathogenic mechanisms and surgical treatment. Retina (Philadelphia, Pa). 2012;32:S205–10.CrossRefPubMed
2.
Zurück zum Zitat Cho H, Choi A, Kang SW. Effect of internal limiting membrane removal in treatment of retinal detachment caused by myopic macular hole. Korean J Ophthalmol. 2004;18(2):141–7.CrossRefPubMed Cho H, Choi A, Kang SW. Effect of internal limiting membrane removal in treatment of retinal detachment caused by myopic macular hole. Korean J Ophthalmol. 2004;18(2):141–7.CrossRefPubMed
3.
Zurück zum Zitat Cheong KX, Xu L, Ohno-Matsui K, Sabanayagam C, Saw SM, Hoang QV. An evidence-based review of the epidemiology of myopic traction maculopathy. Survey of Ophthalmology. 2022. Cheong KX, Xu L, Ohno-Matsui K, Sabanayagam C, Saw SM, Hoang QV. An evidence-based review of the epidemiology of myopic traction maculopathy. Survey of Ophthalmology. 2022.
4.
Zurück zum Zitat Takahashi H, Tanaka N, Shinohara K, Yokoi T, Yoshida T, Uramoto K, et al. Ultrawidefield optical coherence tomographic imaging of posterior vitreous in eyes with high myopia. Am J Ophthalmol. 2019;206:102–12.CrossRefPubMed Takahashi H, Tanaka N, Shinohara K, Yokoi T, Yoshida T, Uramoto K, et al. Ultrawidefield optical coherence tomographic imaging of posterior vitreous in eyes with high myopia. Am J Ophthalmol. 2019;206:102–12.CrossRefPubMed
5.
Zurück zum Zitat Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, et al. IMI–Defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20–30.CrossRefPubMedPubMedCentral Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, et al. IMI–Defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60(3):M20–30.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat García-Ben A, Blanco MJ, Piñeiro A, Mera P, Rodriguez-Alvarez MX, Capeans C. Relationship between macular bending and foveoschisis in myopic patients. Optom Vis Sci. 2014;91(5):497–506.CrossRefPubMed García-Ben A, Blanco MJ, Piñeiro A, Mera P, Rodriguez-Alvarez MX, Capeans C. Relationship between macular bending and foveoschisis in myopic patients. Optom Vis Sci. 2014;91(5):497–506.CrossRefPubMed
7.
Zurück zum Zitat Ouyang P-B, Duan X-C, Zhu X-H. Diagnosis and treatment of myopic traction maculopathy. Int J Ophthalmol. 2012;5(6):754.PubMedPubMedCentral Ouyang P-B, Duan X-C, Zhu X-H. Diagnosis and treatment of myopic traction maculopathy. Int J Ophthalmol. 2012;5(6):754.PubMedPubMedCentral
8.
Zurück zum Zitat Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy. Arch Ophthalmol. 2004;122(10):1455–60.CrossRefPubMed Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy. Arch Ophthalmol. 2004;122(10):1455–60.CrossRefPubMed
9.
Zurück zum Zitat Yeh SI, Chang WC, Chen LJ. Vitrectomy without internal limiting membrane peeling for macular retinoschisis and foveal detachment in highly myopic eyes. Acta Ophthalmol. 2008;86(2):219–24.CrossRefPubMed Yeh SI, Chang WC, Chen LJ. Vitrectomy without internal limiting membrane peeling for macular retinoschisis and foveal detachment in highly myopic eyes. Acta Ophthalmol. 2008;86(2):219–24.CrossRefPubMed
10.
Zurück zum Zitat Gómez-Resa M, Burés-Jelstrup A, Mateo C. Myopic traction maculopathy. Microincision Vitrectomy. Surgery. 2014;54:204–12. Gómez-Resa M, Burés-Jelstrup A, Mateo C. Myopic traction maculopathy. Microincision Vitrectomy. Surgery. 2014;54:204–12.
11.
Zurück zum Zitat Benhamou N, Massin P, Haouchine B, Erginay A, Gaudric A. Macular retinoschisis in highly myopic eyes. Am J Ophthalmol. 2002;133(6):794–800.CrossRefPubMed Benhamou N, Massin P, Haouchine B, Erginay A, Gaudric A. Macular retinoschisis in highly myopic eyes. Am J Ophthalmol. 2002;133(6):794–800.CrossRefPubMed
12.
Zurück zum Zitat Gaucher D, Haouchine B, Tadayoni R, Massin P, Erginay A. Benhha ou N. et a1. Long term follow—up of high myopic foveoschisiisNamral course and surgical outcomel JI Am JOphthalmoZ. 2007;143(3):455_62. Gaucher D, Haouchine B, Tadayoni R, Massin P, Erginay A. Benhha ou N. et a1. Long term follow—up of high myopic foveoschisiisNamral course and surgical outcomel JI Am JOphthalmoZ. 2007;143(3):455_62.
13.
Zurück zum Zitat Wang S-W, Hsia Y, Huang C-J, Hung K-C, Chen M-S, Ho T-C. Biomarkers in the pathogenesis of epiretinal membrane and myopic traction maculopathy: Effects of internal limiting membrane incompliance and posterior staphyloma. Photodiagn Photodyn Ther. 2021;33: 102208.CrossRef Wang S-W, Hsia Y, Huang C-J, Hung K-C, Chen M-S, Ho T-C. Biomarkers in the pathogenesis of epiretinal membrane and myopic traction maculopathy: Effects of internal limiting membrane incompliance and posterior staphyloma. Photodiagn Photodyn Ther. 2021;33: 102208.CrossRef
14.
Zurück zum Zitat Zheng B, Chen Y, Zhao Z, Zhang Z, Zheng J, You Y, et al. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis. Retina. 2011;31(4):692–701.CrossRefPubMed Zheng B, Chen Y, Zhao Z, Zhang Z, Zheng J, You Y, et al. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis. Retina. 2011;31(4):692–701.CrossRefPubMed
15.
Zurück zum Zitat Mateo C, Burés-Jelstrup A, Navarro R, Corcóstegui B. Macular buckling for eyes with myopic foveoschisis secondary to posterior staphyloma. Retina. 2012;32(6):1121–8.CrossRefPubMed Mateo C, Burés-Jelstrup A, Navarro R, Corcóstegui B. Macular buckling for eyes with myopic foveoschisis secondary to posterior staphyloma. Retina. 2012;32(6):1121–8.CrossRefPubMed
16.
Zurück zum Zitat Schepens CL, Okamura I, Brockhurst R. The scleral buckling procedures: 1. Surgical techniques and management. AMA Archives of Ophthalmology. 1957;58(6):797–811.CrossRefPubMed Schepens CL, Okamura I, Brockhurst R. The scleral buckling procedures: 1. Surgical techniques and management. AMA Archives of Ophthalmology. 1957;58(6):797–811.CrossRefPubMed
17.
Zurück zum Zitat Shimada N, Ohno-Matsui K, Yoshida T, Sugamoto Y, Tokoro T, Mochizuki M. Progression from macular retinoschisis to retinal detachment in highly myopic eyes is associated with outer lamellar hole formation. Br J Ophthalmol. 2008;92(6):762–4.CrossRefPubMed Shimada N, Ohno-Matsui K, Yoshida T, Sugamoto Y, Tokoro T, Mochizuki M. Progression from macular retinoschisis to retinal detachment in highly myopic eyes is associated with outer lamellar hole formation. Br J Ophthalmol. 2008;92(6):762–4.CrossRefPubMed
18.
Zurück zum Zitat Shimada N, Sugamoto Y, Ogawa M, Takase H, Ohno-Matsui K. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. Am J Ophthalmol. 2012;154(4):693–701.CrossRefPubMed Shimada N, Sugamoto Y, Ogawa M, Takase H, Ohno-Matsui K. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy. Am J Ophthalmol. 2012;154(4):693–701.CrossRefPubMed
19.
Zurück zum Zitat De Giacinto C, D’Aloisio R, Cirigliano G, Pastore MR, Tognetto D. Autologous neurosensory retinal free patch transplantation for persistent full-thickness macular hole. Int Ophthalmol. 2019;39(5):1147–50.CrossRefPubMed De Giacinto C, D’Aloisio R, Cirigliano G, Pastore MR, Tognetto D. Autologous neurosensory retinal free patch transplantation for persistent full-thickness macular hole. Int Ophthalmol. 2019;39(5):1147–50.CrossRefPubMed
20.
Zurück zum Zitat Chen S-N, Yang C-M. Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies. Retina (Philadelphia, Pa). 2016;36(1):163–70.CrossRefPubMed Chen S-N, Yang C-M. Lens capsular flap transplantation in the management of refractory macular hole from multiple etiologies. Retina (Philadelphia, Pa). 2016;36(1):163–70.CrossRefPubMed
21.
Zurück zum Zitat Lai C-C, Chen Y-P, Wang N-K, Chuang L-H, Liu L, Chen K-J, et al. Vitrectomy with internal limiting membrane repositioning and autologous blood for macular hole retinal detachment in highly myopic eyes. Ophthalmology. 2015;122(9):1889–98.CrossRefPubMed Lai C-C, Chen Y-P, Wang N-K, Chuang L-H, Liu L, Chen K-J, et al. Vitrectomy with internal limiting membrane repositioning and autologous blood for macular hole retinal detachment in highly myopic eyes. Ophthalmology. 2015;122(9):1889–98.CrossRefPubMed
22.
Zurück zum Zitat Kuriyama S, Hayashi H, Jingami Y, Kuramoto N, Akita J, Matsumoto M. Efficacy of inverted internal limiting membrane flap technique for the treatment of macular hole in high myopia. Am J Ophthalmol. 2013;156(1):125-31e1.CrossRefPubMed Kuriyama S, Hayashi H, Jingami Y, Kuramoto N, Akita J, Matsumoto M. Efficacy of inverted internal limiting membrane flap technique for the treatment of macular hole in high myopia. Am J Ophthalmol. 2013;156(1):125-31e1.CrossRefPubMed
23.
Zurück zum Zitat Michalewska Z, Michalewski J, Adelman RA, Nawrocki J. Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology. 2010;117(10):2018–25.CrossRefPubMed Michalewska Z, Michalewski J, Adelman RA, Nawrocki J. Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology. 2010;117(10):2018–25.CrossRefPubMed
24.
Zurück zum Zitat Chen S-N, Hsieh Y-T, Yang C-M. Multiple free internal limiting membrane flap insertion in the treatment of macular hole-associated retinal detachment in high myopia. Ophthalmologica. 2018;240(3):143–9.CrossRefPubMed Chen S-N, Hsieh Y-T, Yang C-M. Multiple free internal limiting membrane flap insertion in the treatment of macular hole-associated retinal detachment in high myopia. Ophthalmologica. 2018;240(3):143–9.CrossRefPubMed
25.
Zurück zum Zitat Hu Z, Lin H, Liang Q, Wu R. Comparing the inverted internal limiting membrane flap with autologous blood technique to internal limiting membrane insertion for the repair of refractory macular hole. Int Ophthalmol. 2020;40(1):141–9.CrossRefPubMed Hu Z, Lin H, Liang Q, Wu R. Comparing the inverted internal limiting membrane flap with autologous blood technique to internal limiting membrane insertion for the repair of refractory macular hole. Int Ophthalmol. 2020;40(1):141–9.CrossRefPubMed
26.
Zurück zum Zitat Ho T-C, Yang C-M, Huang J-S, Yang C-H, Yeh P-T, Chen T-C, et al. Long-term outcome of foveolar internal limiting membrane nonpeeling for myopic traction maculopathy. Retina (Philadelphia, Pa). 2014;34(9):1833–40.CrossRefPubMed Ho T-C, Yang C-M, Huang J-S, Yang C-H, Yeh P-T, Chen T-C, et al. Long-term outcome of foveolar internal limiting membrane nonpeeling for myopic traction maculopathy. Retina (Philadelphia, Pa). 2014;34(9):1833–40.CrossRefPubMed
27.
Zurück zum Zitat Tian T, Jin H, Zhang Q, Zhang X, Zhang H, Zhao P. Long-term surgical outcomes of multiple parfoveolar curvilinear internal limiting membrane peeling for myopic foveoschisis. Eye. 2018;32(11):1783–9.CrossRefPubMedPubMedCentral Tian T, Jin H, Zhang Q, Zhang X, Zhang H, Zhao P. Long-term surgical outcomes of multiple parfoveolar curvilinear internal limiting membrane peeling for myopic foveoschisis. Eye. 2018;32(11):1783–9.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Chen G, Mao S, Tong Y, Jiang F, Yang J, Li W. Fovea sparing versus complete internal limiting membrane peeling for myopic traction maculopathy: a meta-analysis. Int Ophthalmol. 2022;42(3):765–73.CrossRefPubMed Chen G, Mao S, Tong Y, Jiang F, Yang J, Li W. Fovea sparing versus complete internal limiting membrane peeling for myopic traction maculopathy: a meta-analysis. Int Ophthalmol. 2022;42(3):765–73.CrossRefPubMed
29.
Zurück zum Zitat Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994:1088-101. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994:1088-101.
31.
Zurück zum Zitat Xin W-J, Jiang J-Z, Ji L-B, Lv W-J, Gu Y-X, Xiao Y. Efficiency comparison with fovea-sparing internal limiting membrane peeling and complete internal limiting membrane peeling for treating myopic traction maculopathy. Graefes Arch Clin Exp Ophthalmol. 2022;260(1):73–81.CrossRefPubMed Xin W-J, Jiang J-Z, Ji L-B, Lv W-J, Gu Y-X, Xiao Y. Efficiency comparison with fovea-sparing internal limiting membrane peeling and complete internal limiting membrane peeling for treating myopic traction maculopathy. Graefes Arch Clin Exp Ophthalmol. 2022;260(1):73–81.CrossRefPubMed
32.
Zurück zum Zitat Elwan MM, Abd Elghafar AE, Hagras SM, Abou Samra WA, Saleh SM. Long-term outcome of internal limiting membrane peeling with and without foveal sparing in myopic foveoschisis. Eur J Ophthalmol. 2019;29(1):69–74.CrossRefPubMed Elwan MM, Abd Elghafar AE, Hagras SM, Abou Samra WA, Saleh SM. Long-term outcome of internal limiting membrane peeling with and without foveal sparing in myopic foveoschisis. Eur J Ophthalmol. 2019;29(1):69–74.CrossRefPubMed
33.
Zurück zum Zitat Iwasaki M, Miyamoto H, Okushiba U, Imaizumi H. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy. Jpn J Ophthalmol. 2020;64(1):13–21.CrossRefPubMed Iwasaki M, Miyamoto H, Okushiba U, Imaizumi H. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy. Jpn J Ophthalmol. 2020;64(1):13–21.CrossRefPubMed
34.
Zurück zum Zitat Wang L, Wang Y, Li Y, Yan Z, Li Y, Lu L, et al. Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis. Medicine. 2019;98(9). Wang L, Wang Y, Li Y, Yan Z, Li Y, Lu L, et al. Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis. Medicine. 2019;98(9).
35.
Zurück zum Zitat Shiraki N, Wakabayashi T, Ikuno Y, Matsumura N, Sato S, Sakaguchi H, et al. Fovea-sparing versus standard internal limiting membrane peeling for myopic traction maculopathy: a study of 102 consecutive cases. Ophthalmology Retina. 2020;4(12):1170–80.CrossRefPubMed Shiraki N, Wakabayashi T, Ikuno Y, Matsumura N, Sato S, Sakaguchi H, et al. Fovea-sparing versus standard internal limiting membrane peeling for myopic traction maculopathy: a study of 102 consecutive cases. Ophthalmology Retina. 2020;4(12):1170–80.CrossRefPubMed
36.
Zurück zum Zitat ZHU L, CHEN X, YAN Y, DING Q, HU C, HUANG Z. Comparison of the efficacy of vitrectomy combined with complete internal limiting membrane peeling and fovea-sparing internal limiting membrane peeling for high myopia macular foveoschisis. Chin J Ocular Fundus Dis. 2020:509-13. ZHU L, CHEN X, YAN Y, DING Q, HU C, HUANG Z. Comparison of the efficacy of vitrectomy combined with complete internal limiting membrane peeling and fovea-sparing internal limiting membrane peeling for high myopia macular foveoschisis. Chin J Ocular Fundus Dis. 2020:509-13.
37.
Zurück zum Zitat Wu J, Xu Q, Luan J. Vitrectomy with fovea-sparing ILM peeling versus total ILM peeling for myopic traction maculopathy: a meta-analysis. Eur J Ophthalmol. 2021;31(5):2596–605.CrossRefPubMed Wu J, Xu Q, Luan J. Vitrectomy with fovea-sparing ILM peeling versus total ILM peeling for myopic traction maculopathy: a meta-analysis. Eur J Ophthalmol. 2021;31(5):2596–605.CrossRefPubMed
38.
Zurück zum Zitat Ikuno Y, Sayanagi K, Oshima T, Gomi F, Kusaka S, Kamei M, et al. Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol. 2003;136(3):477–81.CrossRefPubMed Ikuno Y, Sayanagi K, Oshima T, Gomi F, Kusaka S, Kamei M, et al. Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol. 2003;136(3):477–81.CrossRefPubMed
39.
Zurück zum Zitat Rubinstein A, Bates R, Benjamin L, Shaikh A. Iatrogenic eccentric full thickness macular holes following vitrectomy with ILM peeling for idiopathic macular holes. Eye. 2005;19(12):1333–5.CrossRefPubMed Rubinstein A, Bates R, Benjamin L, Shaikh A. Iatrogenic eccentric full thickness macular holes following vitrectomy with ILM peeling for idiopathic macular holes. Eye. 2005;19(12):1333–5.CrossRefPubMed
40.
Zurück zum Zitat Hussain N, Mitra S. Multiple extrafoveal macular holes following internal limiting membrane peeling. Int Med Case Rep J. 2018:105–11. Hussain N, Mitra S. Multiple extrafoveal macular holes following internal limiting membrane peeling. Int Med Case Rep J. 2018:105–11.
Metadaten
Titel
Novel surgical approaches for treating myopic traction maculopathy: a meta-analysis
verfasst von
Miguel A. Quiroz-Reyes
Erick A. Quiroz-Gonzalez
Miguel A. Quiroz-Gonzalez
Virgilio Lima-Gomez
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2024
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-024-03374-0

Weitere Artikel der Ausgabe 1/2024

BMC Ophthalmology 1/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.